ScoreWhy is Vivo Bio Tech Ltd. ?
1
Weak Long Term Fundamental Strength with a -0.84% CAGR growth in Net Sales over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.84
- The company has been able to generate a Return on Equity (avg) of 6.60% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
- PAT(9M) At Rs 3.27 cr has Grown at -46.74%
- ROCE(HY) Lowest at 7.95%
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.54 times
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -27.33% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Vivo Bio Tech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Vivo Bio Tech
-27.33%
-0.57
48.07%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.84%
EBIT Growth (5y)
5.53%
EBIT to Interest (avg)
1.84
Debt to EBITDA (avg)
2.75
Net Debt to Equity (avg)
0.58
Sales to Capital Employed (avg)
0.47
Tax Ratio
28.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.59%
ROE (avg)
6.60%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
34
Price to Book Value
0.66
EV to EBIT
10.01
EV to EBITDA
5.48
EV to Capital Employed
0.78
EV to Sales
2.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.81%
ROE (Latest)
4.30%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET SALES(Q)
Highest at Rs 13.11 cr
OPERATING PROFIT TO INTEREST(Q)
Highest at 3.68 times
DEBT-EQUITY RATIO(HY)
Lowest at 0.58 times
-10What is not working for the Company
PAT(9M)
At Rs 3.27 cr has Grown at -46.74%
ROCE(HY)
Lowest at 7.95%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.54 times
EPS(Q)
Lowest at Rs 0.39
Loading Valuation Snapshot...
Here's what is working for Vivo Bio Tech
Net Sales - Quarterly
Highest at Rs 13.11 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 3.68 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debt-Equity Ratio - Half Yearly
Lowest at 0.58 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Vivo Bio Tech
Profit After Tax (PAT) - Latest six months
At Rs 2.21 cr has Grown at -59.07%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.39
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Debtors Turnover Ratio- Half Yearly
Lowest at 3.54 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
